India, July 1 -- image credit- freepik

Mankind Pharma has announced a strategic collaboration with Armenia-based Denovo Sciences to launch an AI-led drug discovery programme, marking an important step in the company's focus on innovation-driven and technology-enabled research and development.

The partnership will bring together Mankind Pharma's strong R&D capabilities, experimental validation infrastructure, and clinical development expertise with Denovo Sciences' proprietary platform for AI-driven molecular generation and prioritisation.

Together, both organisations will work under a human-in-the-loop model, where AI generates and evaluates molecular candidates while scientific experts guide, validate, and refine the results at every ...